Crushing pills for GVHD: does it change the drug?

NCT ID NCT07127926

First seen Feb 04, 2026 · Last updated May 04, 2026 · Updated 10 times

Summary

This study looks at whether crushing belumosudil tablets affects how the drug is absorbed in people with chronic graft-versus-host disease (cGVHD). Eight adults who have had a stem cell transplant will take the drug as a whole tablet and later as a crushed tablet in water. The goal is to see if crushing changes drug levels in the blood, which could impact safety or effectiveness. This is a small, early-stage study focused on drug behavior, not long-term outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Texas M. D. Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.